Universal screening at age 1-2 years as an adjunct to cascade testing for familial hypercholesterolaemia in the UK: A cost-utility analysis. [electronic resource]
Producer: 20191022Description: 434-443 p. digitalISSN:- 1879-1484
- Age Factors
- Blood Chemical Analysis -- economics
- Cholesterol -- blood
- Clinical Decision-Making
- Cost-Benefit Analysis
- DNA Mutational Analysis -- economics
- Decision Support Techniques
- Decision Trees
- Genetic Markers
- Genetic Predisposition to Disease
- Health Care Costs
- Humans
- Hyperlipoproteinemia Type II -- blood
- Infant
- Markov Chains
- Mass Screening -- economics
- Models, Economic
- Mutation
- Phenotype
- Predictive Value of Tests
- Prognosis
- Quality of Life
- Quality-Adjusted Life Years
- Time Factors
- United Kingdom
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.